Literature DB >> 20835521

Methemoglobinemia and dapsone levels in patients with leprosy.

Jose Luiz Fernandes Vieira1, Juan Gonzalo Bardarez Riveira, Ana de Nazaré Silva Martins, Jorge Pereira da Silva, Claudio Guedes Salgado.   

Abstract

The objective of this work was to determine the methemoglobinemia and correlate with dapsone levels in multibacillary leprosy patients under leprosy multi-drug therapy. Thirty patients with laboratory and clinical diagnosis of multibacillary leprosy were enrolled. Dapsone was analyzed by high performance liquid chromatography and methemoglobinemia by spectrophotometry. The mean dapsone concentrations in male was 1.42 g/mL and in female was 2.42 g/mL. The mean methemoglobin levels in male was 3.09 µg/mL; 191%, and in female was 2.84 ± 1.67%. No correlations were seen between dapsone levels and methemoglobin in male and female patients. Our results demonstrated that the dosage of dapsone in leprosy treatment does not promote a significant methemoglobinemia.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20835521     DOI: 10.1590/s1413-86702010000300022

Source DB:  PubMed          Journal:  Braz J Infect Dis        ISSN: 1413-8670            Impact factor:   1.949


  3 in total

1.  Subtle case of dapsone-induced methaemoglobinaemia.

Authors:  Justin S Lewis; Zachary G Jacobs
Journal:  BMJ Case Rep       Date:  2020-08-24

2.  The mystery of 'saturation gap': a case of dapsone-induced methaemoglobinemia in a pregnant mother with leprosy.

Authors:  Andy Sing Ong Tang; Siaw Tze Yeo; Yeon Chiat Teh; Wee Meng Kho; Lee Ping Chew; Pubalan Muniandy
Journal:  Oxf Med Case Reports       Date:  2019-01-24

3.  Clinical oxidative stress during leprosy multidrug therapy: impact of dapsone oxidation.

Authors:  Taysa Ribeiro Schalcher; Rosivaldo S Borges; Michael D Coleman; João Batista Júnior; Claudio G Salgado; Jose Luiz F Vieira; Pedro R T Romão; Fabio R Oliveira; Marta Chagas Monteiro
Journal:  PLoS One       Date:  2014-01-22       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.